Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-044067
Filing Date
2023-04-11
Accepted
2023-04-11 16:36:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2312033d1_defa14a.htm DEFA14A 13132
2 GRAPHIC tm2312033d1_defa14aimg001.jpg GRAPHIC 162056
3 GRAPHIC tm2312033d1_defa14aimg002.jpg GRAPHIC 151634
  Complete submission text file 0001104659-23-044067.txt   446516
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 23813774
SIC: 2834 Pharmaceutical Preparations